Researchers sought to better understand the risk for recurrence and precipitants for relapse in anterior uveitis, potentially allowing clinicians to better provide a prognosis and disease course with ...
Conjunctival hyperemia in the right eye (Panel A) and left eye (Panel B) 8 days after the onset of systemic symptoms is shown. Also shown are keratic precipitates and grade 2+ inflammatory cells (on a ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives ...
Aldeyra, which focuses on therapies for immune-mediated diseases, reported its Phase 3 trial dubbed SOLACE that evaluated its reproxalap, code-named ADX-102 (a topical ophthalmic solution) in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback